 Lung transplantation has been shown to be a successful treatment option for many patients suffering from end-stage lung diseases. However, despite increasing numbers of lung transplants performed every year, there remains a significant gap between the number of organs available and the number of patients who need them. In order to ensure the best possible outcomes, researchers have focused their efforts on identifying those patients most likely to benefit from this procedure. This includes understanding which diseases are more likely to occur after transplantation and how these can be managed. This article was authored by Doreen Arama Esendali, Prinsantia Moa, Ilif Kupali, and others.